120 results
Page 4 of 6
S-4
EX-4.6
vh4i79gcc ja5g9niy
23 Dec 22
Registration of securities issued in business combination transactions
6:06am
S-4
EX-10.27
iowr2z2g 3lf0rf7j
23 Dec 22
Registration of securities issued in business combination transactions
6:06am
S-4
EX-10.36
az09wcbi
23 Dec 22
Registration of securities issued in business combination transactions
6:06am
S-4
EX-10.31
ook9lz v0n2jwb
23 Dec 22
Registration of securities issued in business combination transactions
6:06am
S-4
EX-10.34
l08kzsj7x0lih
23 Dec 22
Registration of securities issued in business combination transactions
6:06am
S-4
EX-10.23
zflp7elle33 foocpm
23 Dec 22
Registration of securities issued in business combination transactions
6:06am
8-K
EX-10.3
89yapfr2mmro9 t3
13 Dec 22
Vallon Pharmaceuticals and GRI Bio Enter into Merger Agreement with Goal of Advancing Innovative Pipeline of NKT Cell Regulators
4:09pm
8-K
EX-99.2
eicogu lwkyomr
13 Dec 22
Vallon Pharmaceuticals and GRI Bio Enter into Merger Agreement with Goal of Advancing Innovative Pipeline of NKT Cell Regulators
4:09pm
8-K
EX-10.5
jmnel5gpuboq 8p
13 Dec 22
Vallon Pharmaceuticals and GRI Bio Enter into Merger Agreement with Goal of Advancing Innovative Pipeline of NKT Cell Regulators
4:09pm
8-K
EX-10.2
pmpiaos vz
13 Dec 22
Vallon Pharmaceuticals and GRI Bio Enter into Merger Agreement with Goal of Advancing Innovative Pipeline of NKT Cell Regulators
4:09pm
8-K
EX-10.4
5t0ne
13 Dec 22
Vallon Pharmaceuticals and GRI Bio Enter into Merger Agreement with Goal of Advancing Innovative Pipeline of NKT Cell Regulators
4:09pm
8-K
7bupcul1eqa sdlpa
13 Dec 22
Vallon Pharmaceuticals and GRI Bio Enter into Merger Agreement with Goal of Advancing Innovative Pipeline of NKT Cell Regulators
4:09pm
8-K
EX-2.1
m99nr8 by8t9pv
13 Dec 22
Vallon Pharmaceuticals and GRI Bio Enter into Merger Agreement with Goal of Advancing Innovative Pipeline of NKT Cell Regulators
4:09pm
8-K
EX-10.1
nwyln8nqk8jja9sjuikk
13 Dec 22
Vallon Pharmaceuticals and GRI Bio Enter into Merger Agreement with Goal of Advancing Innovative Pipeline of NKT Cell Regulators
4:09pm
PRE 14A
853kuwnohzwem8h
25 May 22
Preliminary proxy
11:58am
8-K
EX-10.2
ug01kxqse
13 May 22
Vallon Pharmaceuticals Announces $3.9 Million Registered Direct Offering
5:12pm
8-K
EX-4.1
ssg enl9piy
13 May 22
Vallon Pharmaceuticals Announces $3.9 Million Registered Direct Offering
5:12pm